References
1. Dowhan W, Bodanov H, Mileykovskaya E: Functional roles of lipids in membranes. In: Biochemistry of Lipids, Lipoproteins and Membranes, 5th ed. Vance DE, Vance JE (editors). Elsevier, 2008:1–37.
2. Benzie IFF: Lipid peroxidation: a review of causes, consequences, measurement and dietary influences. Int J Food Sci Nutr 1996;47:233.
3. Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Jama 2001;285:2486–2497.
4. Anderson TJ, Gregoire J, Hegele RA, et al. 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. Canadian Journal of Cardiology 2013; (29) 151–167
5. Dawber TR et al. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health, Mar 1951; 41: 279 - 286.
6. Grundy SM et al. Primary prevention of coronary heart disease; guidance from Framingham: a statement for healthcare professionals from the American Heart Association task force on risk reduction. Circulation, 1998;97:1876-1887.
7. Cooney MT et al. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. J Am Coll Cardiol 2009;54:1209–27
8. Lloyd-Jones DM, Nam BH, D’Agostino RBS, et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged
adults: a prospective study of parents and offspring. JAMA 2004;291: 2204-11.
9. Statistics Canada. Heart health and cholesterol levels of Canadians, 2007 to 2009. http://www.statcan.gc.ca/pub/82-625-x/2010001/article/11136-eng.htm. Accessed May 26, 2013
10. Statistics Canada. Access to a regular medical doctor, 2010. http://www.statcan.gc.ca/pub/82-625-x/2011001/article/11456-eng.htm. Accessed May 28, 2013
11. Heart and Stroke foundation: Statistics. http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.3483991/. Accessed June 3, 2013
12. Lugomirski P, Guo H, Boom NK. Quality of Diabetes and Hyperlipidemia Screening Before a First Myocardial Infarction.
Canadian Journal of Cardiology 2013; 1-6
13. Tonelli M, Muntner P, Lloyd A, et al. Association between LDL-C and Risk of Myocardial Infarction in CKD. J Am Soc Nephrol. 2013 May;24(6):979-86.
14. Gupta M, Singh N, Tsigoulis M, et al. Perceptions of Canadian primary care physicians towards cardiovascular risk assessment and lipid management. Can J Cardiol 2012;28:14-9.3. Lopukhin YM. The skin and atherosclerosis (a three-drop test). Physicochem Aspects Med Rev 1992;3:1–124.
15. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002;288:462-7.
16. Simons LA, Levis G, Simons J. Apparent discontinuation rates in patients prescribed lipid-lowering drugs. Med J Aust 1996;164:208-11.
17. Rodondi N, Locatelli I, Aujesky D, et al. Framingham risk score and alternatives for prediction of coronary heart disease in older adults. PLoS
One 2012;7:e34287.
18. Prevu QuickFact Sheet. http://www.prevu.com/English/hcp/pdfs/prevufactsheet.pdf. Accessed June 2, 2013
19.Prevu POC Test mechanism of action. http://www.prevu.com/English/hcp/poc_test.html. Accessed May 23, 2013
20. Pear Healthcare Solutions Inc, http://www.pearhealthcare.com/device-PreVu.php. Accessed June 1, 2013
21. Soureti A, Hurling R, Murray P, van Mechelen W, Cobain M. Evaluation of a cardiovascular disease risk assessment tool for the promotion of
healthier lifestyles. Eur J Cardiovasc Prev Rehabil 2010;17:519-23.
22. Ebrahim S, Taylor F, Ward K, Beswick A, Burke M, Davey Smith G.Multiple risk factor interventions for primary prevention of coronary
heart disease. Cochrane Database Syst Rev 2011;CD001561.
23. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
24. Kodama S, Tanaka S, Saito K, et al. Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. Arch Intern Med 2007;167:999-1008.
2. Benzie IFF: Lipid peroxidation: a review of causes, consequences, measurement and dietary influences. Int J Food Sci Nutr 1996;47:233.
3. Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Jama 2001;285:2486–2497.
4. Anderson TJ, Gregoire J, Hegele RA, et al. 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. Canadian Journal of Cardiology 2013; (29) 151–167
5. Dawber TR et al. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health, Mar 1951; 41: 279 - 286.
6. Grundy SM et al. Primary prevention of coronary heart disease; guidance from Framingham: a statement for healthcare professionals from the American Heart Association task force on risk reduction. Circulation, 1998;97:1876-1887.
7. Cooney MT et al. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. J Am Coll Cardiol 2009;54:1209–27
8. Lloyd-Jones DM, Nam BH, D’Agostino RBS, et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged
adults: a prospective study of parents and offspring. JAMA 2004;291: 2204-11.
9. Statistics Canada. Heart health and cholesterol levels of Canadians, 2007 to 2009. http://www.statcan.gc.ca/pub/82-625-x/2010001/article/11136-eng.htm. Accessed May 26, 2013
10. Statistics Canada. Access to a regular medical doctor, 2010. http://www.statcan.gc.ca/pub/82-625-x/2011001/article/11456-eng.htm. Accessed May 28, 2013
11. Heart and Stroke foundation: Statistics. http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.3483991/. Accessed June 3, 2013
12. Lugomirski P, Guo H, Boom NK. Quality of Diabetes and Hyperlipidemia Screening Before a First Myocardial Infarction.
Canadian Journal of Cardiology 2013; 1-6
13. Tonelli M, Muntner P, Lloyd A, et al. Association between LDL-C and Risk of Myocardial Infarction in CKD. J Am Soc Nephrol. 2013 May;24(6):979-86.
14. Gupta M, Singh N, Tsigoulis M, et al. Perceptions of Canadian primary care physicians towards cardiovascular risk assessment and lipid management. Can J Cardiol 2012;28:14-9.3. Lopukhin YM. The skin and atherosclerosis (a three-drop test). Physicochem Aspects Med Rev 1992;3:1–124.
15. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002;288:462-7.
16. Simons LA, Levis G, Simons J. Apparent discontinuation rates in patients prescribed lipid-lowering drugs. Med J Aust 1996;164:208-11.
17. Rodondi N, Locatelli I, Aujesky D, et al. Framingham risk score and alternatives for prediction of coronary heart disease in older adults. PLoS
One 2012;7:e34287.
18. Prevu QuickFact Sheet. http://www.prevu.com/English/hcp/pdfs/prevufactsheet.pdf. Accessed June 2, 2013
19.Prevu POC Test mechanism of action. http://www.prevu.com/English/hcp/poc_test.html. Accessed May 23, 2013
20. Pear Healthcare Solutions Inc, http://www.pearhealthcare.com/device-PreVu.php. Accessed June 1, 2013
21. Soureti A, Hurling R, Murray P, van Mechelen W, Cobain M. Evaluation of a cardiovascular disease risk assessment tool for the promotion of
healthier lifestyles. Eur J Cardiovasc Prev Rehabil 2010;17:519-23.
22. Ebrahim S, Taylor F, Ward K, Beswick A, Burke M, Davey Smith G.Multiple risk factor interventions for primary prevention of coronary
heart disease. Cochrane Database Syst Rev 2011;CD001561.
23. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
24. Kodama S, Tanaka S, Saito K, et al. Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. Arch Intern Med 2007;167:999-1008.